Polyunsaturated fatty acids and human health: A critical appraisal of the evidence

Current Pharmaceutical Design

Volumn 15, Issue 36, 2009, Pages 4085-4086

  Cherubini, A ^a   Ruggiero, C ^a   Lattanzio, F ^b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b INRCA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID;

ANTIINFLAMMATORY ACTIVITY; BODY COMPOSITION; CARDIOVASCULAR DISEASE; DEMENTIA; DEPRESSION; DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG MECHANISM; EDITORIAL; HEALTH CARE; HUMAN; HYPERTRIGLYCERIDEMIA; KIDNEY DISEASE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OSTEOPOROSIS; PRIORITY JOURNAL; PUBLIC HEALTH; RISK REDUCTION;

BODY COMPOSITION; CARDIOVASCULAR DISEASES; DEPRESSION; FATTY ACIDS, UNSATURATED; HUMANS; HYPERLIPIDEMIAS; INFLAMMATION; KIDNEY DISEASES; OSTEOPOROSIS;

EID: 71849085164     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161209789909737     Document Type: Editorial

References (14)

1. Dyerberg J. Coronary heart disease in Greenland Inuit: a paradox. Implications for western diet patterns. Arctic Med Res 1989; 48:47-54.
2. th 2009
3. Zuliani G, Galvani M, Leitersdorf E, Volpato S, Cavalieri M, Fellin R. The role of polyunsaturated fatty acids (pufa) in the treatment of dyslipidemias. Curr Pharm Des 2009; 15(36): 4087-4093.
4. Calzolari I, Fumagalli S, Marchionni N, Di Bari M. Polyunsaturated fatty acids and cardiovascular disease. Curr Pharm Des 2009; 15(36): 4094-4102.
5. Rohrbach S. Effects of dietary polyunsaturated fatty acids on mitochondria. Curr Pharm Des 2009; 15(36): 4103-4116.
6. Menéndez de la Granda BM, Sinclair AJ. Fatty acids and obesity. Curr Pharm Des 2009; 15(36): 4117-4125.
7. Abbatecola AM, Evans W, Paolisso G. Pufa supplements and type 2 diabetes in the elderly. Curr Pharm Des 2009; 15(36): 4126-4134.
8. Ferrucci L, Cherubini A, Bandinelli S, Bartali B, Corsi A, Lauretani F, et al. Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. J Clin Endocrinol Metab 2006; 91: 439-446 (Pubitemid 43236907)
9. Ruggiero C, Cherubini A, Gasperini B, Lattanzio F. ω-3 polyunsaturated fatty acids and immune-mediated diseases: inflammatory bowel disease and rheumatoid arthritis. Curr Pharm Des 2009; 15(36): 4135-4148.
10. Lauretani F, Maggio M, Pizzarelli F, Michelassi S, Ceda GP, Bandinelli S, et al. Omega-3 and Renal Function in Older Adults. Curr Pharm Des 2009; 15(36): 4149-4156.
11. Maggio M, Artoni A, Lauretani F, Borghi L, Nouvenne A, Valenti G, et al. The impact of omega-3 on osteoporosis. Curr Pharm Des 2009; 15(36): 4157-4164.
12. Liperoti R, Landi F, Fusco O, Bernabei R, Onder G. Omega-3 polyunsaturated fatty acids and depression: a review of the evidence. Curr Pharm Des 2009; 15(36): 4165-4172.
13. Carrié I, Abellan Van Kan G, Rolland Y, Gillette-Guyonnet S, Vellas B Pufa for prevention and treatment of dementia? Curr Pharm Des 2009; 15(36): 4173-4185.
14. Abete P, Testa G, Galizia G, Della-Morte D, Cacciatore F, Rengo F. PUFA for human health: diet or supplementation? Curr Pharm Des 2009; 15(36): 4186-4190.